11
Clinical Trials associated with Recombinant human growth hormone(Changchun Genescience)重组人生长激素注射液治疗因软骨发育不全所引起的儿童身材矮小的有效性和安全性的多中心、开放性、单臂 IV 期临床试验
[Translation] A multicenter, open-label, single-arm phase IV clinical trial of the efficacy and safety of recombinant human growth hormone injection in the treatment of short stature in children caused by achondroplasia
评估重组人生长激素注射液治疗因软骨发育不全所引起的儿童身材矮小的有效性和安全性性
[Translation] To evaluate the efficacy and safety of recombinant human growth hormone injection in the treatment of short stature in children due to achondroplasia
重组人生长激素注射液治疗肾移植前慢性肾脏疾病(CKD)引起的儿童生长障碍疗效和安全性的Ⅲ期临床试验
[Translation] Phase III clinical trial of the efficacy and safety of recombinant human growth hormone injection in the treatment of growth disorders in children caused by chronic kidney disease (CKD) before renal transplantation
评价 rhGH 注射液对肾移植前 CKD 引起生长障碍儿童的身高标准 差积分(HT SDS)的改善,以及评价生长速率、骨成熟情况(BA/CA)、IGF-1SDS 的改变、IGF-1/IGFBP-3 摩尔比的改变等
[Translation] To evaluate the effect of rhGH injection on the height standard deviation score (HT SDS) of children with growth disorders caused by CKD before renal transplantation, as well as the changes in growth rate, bone maturation (BA/CA), IGF-1 SDS, and IGF-1/IGFBP-3 molar ratio.
重组人生长激素注射液(赛增?)治疗特发性矮小的临床试验多中心、开放、无对照、观察性研究
[Translation] Clinical trial of recombinant human growth hormone injection (Saizen?) for the treatment of idiopathic short stature: a multicenter, open, uncontrolled, observational study
评估重组人生长激素注射液(赛增®)治疗ISS儿童2年的安全性和有效性
[Translation] To evaluate the safety and efficacy of recombinant human growth hormone injection (Saizen®) in the treatment of children with ISS for 2 years
100 Clinical Results associated with Recombinant human growth hormone(Changchun Genescience)
100 Translational Medicine associated with Recombinant human growth hormone(Changchun Genescience)
100 Patents (Medical) associated with Recombinant human growth hormone(Changchun Genescience)
100 Deals associated with Recombinant human growth hormone(Changchun Genescience)